Latest news, press releases, and SEC filings for ASBPW (ASBPW) https://caymanjournal.com/stock/ASBPW en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 04:32:11 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is an **amended registration statement (S-1/A)**. Think of it as the final paperwork needed to let certain investors sell the shares they recently bought from the company. * **Why it exists:** Aspire Biopharma raised $11 million in February 2026 by selling special https://caymanjournal.com/stock/ASBPW/sec-filing/0001493152-26-016123 https://caymanjournal.com/stock/ASBPW/sec-filing/0001493152-26-016123 Fri, 10 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is Aspire Biopharma's **10-K annual report**, the comprehensive yearly filing required by the SEC for public companies. It’s a deep dive into their business operations, financial performance, and the risks they face. Think of it as the company's official report card f https://caymanjournal.com/stock/ASBPW/sec-filing/0001493152-26-013682 https://caymanjournal.com/stock/ASBPW/sec-filing/0001493152-26-013682 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing